mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization - Concepedia

Concepedia

Publication | Open Access

mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization

DOI Full Paper Access

21

Citations

22

References

2013

Year

Hippocrates Moschouris, Katerina Malagari, Marina Papadaki, Ioannis Kornezos, Konstantinos Stamatiou, Katerina Chatzimichael, Nikolaos Kelekis

Diagnostic and Interventional Radiology

Abstract

The mRECIST-CEUS combination is feasible and has prognostic value in the assessment of hepatocellular carcinoma following transarterial chemoembolization.

References

	Year	Citations

Page 1